Based on the initial study on the antiarrhythmic mechanism of the multi-herbal Chinese medicine Xin Su Ning, a five years further research programme has been signed between Shaanxi Momentum Pharmaceutical Co. Ltd, China, and the University of Oxford on 17th September 2015. At the signing ceremony a cooperative Chinese herbal medicine research laboratory at DPAG was granted.
Front row, left to right: Dr Yu-Ling Ma, Mr Wang Bao-An, Professor Peter Robbins.
Back row, left to right: Mr Mao Peng, Dr Zhang Xiao-Xiao, Dr Lisa Heather, Ms Nicola Dixon, Professor Zhao Zheng-Sheng, Mr Wang Bo.
Mr. Wang Bao-An, the CEO of Shaanxi Momentum Pharmaceutical Co. Ltd expressed that he is delighted to have the opportunity to collaborate with the University of Oxford to discover the mechanisms of clinically effective Chinese medicine, and he is looking forward to an even longer term collaboration with the Department in the study of Chinese medicine.
Professor Peter Robbins, Head of Department, said: "In the past two years we have built up understanding and trust with Shaanxi Momentum Pharmaceutical Co. Ltd. With the promising initial research results, which were published at the Joint Australia-British Pharmacology Conference in Hong Kong in May 2015, we are now able to embark on a field of study that will fully use the research strength of the Department and discover the actions of the multi-herbal Chinese medicine."
Dr Yu-Ling Ma, the principal investigator of the five-year programme, said that the research will look into the active components’ actions, individually and in combination, both at cellular level and within biological systems, and the research is expected to explore the essence of the multi-component nature of Chinese medicine.